Anxo Pharmaceutical Co., Ltd. (6677.TWO)

TWD 18.05

(0.84%)

Net Income Summary of Anxo Pharmaceutical Co., Ltd.

  • Anxo Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was 21.86 Million TWD , up 274.08% from previous year.
  • Anxo Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q2 was -17.56 Million TWD , down 0.0% from previous quarter.
  • Anxo Pharmaceutical Co., Ltd. reported an annual net income of -12.55 Million TWD in 2022, down -165.29% from previous year.
  • Anxo Pharmaceutical Co., Ltd. reported an annual net income of 19.23 Million TWD in 2021, down -38.75% from previous year.
  • Anxo Pharmaceutical Co., Ltd. reported a quarterly net income of -17.56 Million TWD for 2024 Q1, down -328.93% from previous quarter.
  • Anxo Pharmaceutical Co., Ltd. reported a quarterly net income of 3.25 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Anxo Pharmaceutical Co., Ltd. (2023 - 2019)

Historical Annual Net Income of Anxo Pharmaceutical Co., Ltd. (2023 - 2019)

Year Net Income Net Income Growth
2023 21.86 Million TWD 274.08%
2022 -12.55 Million TWD -165.29%
2021 19.23 Million TWD -38.75%
2020 31.4 Million TWD 30.21%
2019 24.11 Million TWD 0.0%

Peer Net Income Comparison of Anxo Pharmaceutical Co., Ltd.

Name Net Income Net Income Difference
Allied Biotech Corporation 97.41 Million TWD 77.558%
GeneFerm Biotechnology Co., Ltd. 124.62 Million TWD 82.458%
Easywell Biomedicals, Inc. -144.81 Million TWD 115.095%
TTY Biopharm Company Limited 1.12 Billion TWD 98.063%
Synmosa Biopharma Corporation 594.83 Million TWD 96.325%
Orient EuroPharma Co., Ltd. 143.94 Million TWD 84.813%
Center Laboratories, Inc. -995.42 Million TWD 102.196%
Tien Liang BioTech Co., Ltd. 17.73 Million TWD -23.286%
Orient Pharma Co., Ltd. 22.28 Million TWD 1.916%
InnoPharmax Inc. -70.83 Million TWD 130.864%
Johnson Chemical Pharmaceutical Works Co., Ltd. 79.7 Million TWD 72.571%
Excelsior Biopharma Inc. -91.01 Million TWD 124.02%
DV Biomed Co., Ltd. 162.91 Million TWD 86.581%
Foresee Pharmaceuticals Co., Ltd. -1.03 Billion TWD 102.11%
Handa Pharmaceuticals, Inc. 726.88 Million TWD 96.993%
UniPharma Co., Ltd. -21.81 Million TWD 200.22%
Alar Pharmaceuticals Inc. 382.61 Million TWD 94.286%
Winston Medical Supply Co., Ltd. 158.75 Million TWD 86.23%
Mercury Biopharmaceutical Corporation -43.81 Million TWD 149.893%
Bioray Biotech Co., Ltd -11.55 Million TWD 289.125%
TSH Biopharm Corporation Limited 61.98 Million TWD 64.734%